Welcome to our dedicated page for Birchtech news (Ticker: BCHT), a resource for investors and traders seeking the latest updates and insights on Birchtech stock.
Birchtech Corp. (BCHT) is an industrial company in the pollution and treatment controls industry, focused on specialty activated carbon technologies for sustainable air and water treatment. Its news flow provides insight into the company’s progress across air emissions control, water purification, intellectual property enforcement, and capital markets activity.
News about Birchtech often highlights developments in its SEA ae sorbent technologies for mercury emissions capture in the coal-fired utility sector. Releases describe new non-exclusive licensing agreements with regional coal-fired utilities, including utilities that were previously involved in patent litigation. These items can signal how the company is expanding its base of license and supply relationships and converting technology users into customers.
Another recurring theme in Birchtech’s news is the commercialization of its water treatment solutions. The company has reported initial purchase orders from a large mid-Atlantic power utility for filtration system media replacement services, as well as collaborations with engineering firms such as Civil & Environmental Consultants, Inc. (CEC) to provide Rapid Small-Scale Column Testing (RSSCT) for water utilities. Such updates illustrate how Birchtech is applying its activated carbon expertise to contaminants like PFAS and PFOS.
Investors following BCHT news will also see legal and financial milestones, including court decisions in patent infringement cases and quarterly financial results. The company has reported a final judgment in its favor in a U.S. District Court patent case and provides regular earnings releases and conference call announcements.
Capital markets updates, such as Birchtech’s 1‑for‑5 reverse stock split and its stated uplisting strategy, appear alongside participation in investor conferences and virtual events. For readers tracking BCHT, this news page offers a consolidated view of licensing activity, water business commercialization, litigation outcomes, earnings reports, and stock-related actions. Bookmark this page to monitor how Birchtech’s air and water segments, intellectual property strategy, and capital markets initiatives evolve over time.
Birchtech (NYSE American: BCHT) appointed Michael Mioska, CPA, MBA, as Chief Financial Officer, effective May 5, 2026.
Mioska brings over 20 years of accounting, audit and financial reporting experience, has served as an independent consultant since 2021 and advised Birchtech since 2023, providing familiarity aimed at a seamless transition.
Birchtech (NYSE American: BCHT) will release its first quarter 2026 financial results after market close on May 13, 2026 and will host an investor conference call at 5:00 p.m. Eastern that day.
Dial-in numbers, conference ID 13760298, webcast link, replay details through June 3, 2026, and one-year webcast availability are provided for participants.
Birchtech (NYSE American: BCHT) will exhibit at four water industry conferences in May–June 2026, showcasing water treatment solutions including Design Center Analytical Services, SEA-IX™ nuclear-grade ion exchange resins, and granular activated carbon (GAC) for PFAS removal.
Dr. Nicholas Lentz will deliver a featured presentation on PFAS removal using RSSCTs at the AWWA technical conference, May 4-6, 2026 in State College, Pennsylvania (Booth #57). For meetings contact sales@birchtech.com; more information at www.birchtech.com.
Birchtech (NYSE American: BCHT) reported Q4 2025 results and corporate milestones on March 31, 2026. Product revenues rose 19.8% YoY while total Q4 revenue fell to $3.8M. The company obtained a $78M final judgment, completed an NYSE American uplisting and raised $16.6M.
Management highlighted commercialization progress in water solutions, launch of SEA-IX™, $0.9M in utility purchase orders, and plans to collect the judgment and scale Carbon Rejuvenation™.
Birchtech (NYSE American: BCHT) launched the SEA-IX™ nuclear-grade ion exchange resin line, targeting an estimated $185–$255 million annual addressable market across nuclear, coal-fired utilities, and municipal water treatment.
The U.S.-distributed line offers 11 formulations, shorter lead times, and has $1.0 million purchase orders to-date (including $0.4 million in March 2026); initial customer results show improved throughput and reduced material usage.
Birchtech (NYSE American: BCHT) will release fourth quarter 2025 financial results after market close on Tuesday, March 31, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time the same day to discuss results and provide a corporate update.
Dial-in numbers, conference ID 13759505, webcast link, telephone playback through April 21, 2026, and a one-year webcast replay are provided for investors.
Birchtech (NYSE American: BCHT) management will participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. President and CEO Richard MacPherson will give a webcast presentation and hold one-on-one investor meetings on March 10, 2026 at 12:30 p.m. ET.
A live audio webcast and archived replay will be available via the conference webcast link; registration is required to attend and meetings can be scheduled through MZ Group at the provided contact email.
Birchtech (NYSE American: BCHT) issued a shareholder letter outlining 2025 progress and 2026 priorities. Key points: $78 million federal court judgment, ~$37 million in license fees and settlements since 2020, a $15 million capital raise concurrent with an NYSE American listing, early water-market wins including ~$0.9 million in purchase orders, and plans to build a granular activated carbon rejuvenation facility targeting late 2027.
The company highlights expanding licensing, scaling water treatment pilots, and a strategy to grow recurring supply-and-service revenue.
Birchtech (NYSE American: BCHT) priced an underwritten public offering of 6,250,000 common shares at $2.40 per share for aggregate gross proceeds of approximately $15.0 million. The company granted a 30-day option for an additional 937,500 shares to cover over-allotments.
Proceeds will be used for continuing operating expenses, working capital and general corporate purposes. Birchtech’s common stock will begin trading on the NYSE American on or about February 26, 2026, and OTCQB trading will terminate; the TSX listing will remain.
Birchtech (BCHT) announced it expects to uplist its common stock to the NYSE American, with trading to begin on or about February 12, 2026, subject to final NYSE American authorization and continued compliance.
The company also disclosed a concurrent offering of common stock that is conditioned on the NYSE American listing; additional Offering details will be filed with the SEC. Birchtech will remain listed on the TSX and maintain OTCQB quoting until the NYSE American listing becomes effective. Stockholders need take no action prior to the uplisting.